Nath Bio-Genes (India) share news, announcements and annual reports
NSE: NATHBIOGENBSE: 537291Agricultural Food & other ProductsSmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹131.01.
2 Nov: open ₹131.40, high ₹134.97, low ₹131.01
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹251 Cr2,134th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 6.85
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹7.21 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 8.52
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.37
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.52%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹7.21 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 4.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 5,16988.6% delivered
Nath Bio-Genes (India) share news and announcements
336 announcements, routine notices left out, newest first. Page 4 of 7.
Feb 2021
11 Feb · Analysts
10 Feb · Board meeting
10 Feb · Results
3 Feb · Board meeting
Jan 2021
29 Jan · Updates
Nov 2020
7 Nov · Analysts
7 Nov · Board meeting
7 Nov · Results
Oct 2020
29 Oct · Board meeting
Sep 2020
26 Sep · Updates
22 Sep · Analysts
Aug 2020
13 Aug · Analysts
11 Aug · Updates
10 Aug · Rating
7 Aug · Results
3 Aug · Updates
Jul 2020
31 Jul · Analysts
28 Jul · Board meeting
Jun 2020
15 Jun · Board meeting
15 Jun · Results
13 Jun · Analysts
9 Jun · Board meeting
May 2020
6 May · Legal
Exchange has sought clarification from Nath Bio-Genes (India) Limited with respect to announcement dated 28-Apr-2020 regarding Introduction of New Cotton Hybrids. On basis of above the Company is required to clarify following: 1. Date of launch;2. Category of the product;3. Whether caters to domestic/ international market;4. Name of the countries in which the product is launched (in case of international).The response of the Company is awaited.4 May · Updates
Apr 2020
28 Apr · Updates
21 Apr · Analysts
17 Apr · Legal
The exchange asked on 13 Apr 2020
17 Apr · Updates
Mar 2020
14 Mar · Legal
The exchange asked on 13 Mar 2020
Jan 2020
30 Jan · Results
28 Jan · Analysts
11 Jan · Board meeting
Nov 2019
26 Nov · Related Party Transactions
2 Nov · Results
2 Nov · Board meeting
Oct 2019
25 Oct · Analysts